Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Amedisys (AMED) stocks in Canada
Learn how to easily invest in Amedisys stocks.
Amedisys is a medical care facilities business based in the US. Amedisys stocks (AMED.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $270.32 – a decrease of 1.44% over the previous week. Amedisys employs 21,000 staff and has a trailing 12-month revenue of around $2.2 billion.
How to buy shares in Amedisys
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AMED – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Amedisys stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Amedisys?
- Has coronavirus impacted Amedisys shares?
- Amedisys shares summary
- Compare share dealing platforms
- Is Amedisys stock a buy or sell?
- Amedisys performance over time
- Are Amedisys shares over-valued?
- Amedisys's financials
- How volatile are Amedisys shares?
- Does Amedisys pay a dividend?
- Have Amedisys shares ever split?
- Other common questions
How has Coronavirus impacted Amedisys's stock price?
Since the stock market crash in March caused by coronavirus, Amedisys's stock price has had significant negative movement.
Its last market close was $146.79, which is 24.35% down on its pre-crash value of $194.03 and 10.41% up on the lowest point reached during the March crash when the stocks fell as low as $132.9495.
If you had bought $1,000 worth of Amedisys stocks at the start of February 2020, those stocks would have been worth $938.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $819.09.
Amedisys stock price (NASDAQ:AMED)Use our graph to track the performance of AMED stocks over time.
Amedisys shares at a glance
|Latest market close||$146.79|
|52-week range||$133.62 - $325.12|
|50-day moving average||$162.92|
|200-day moving average||$209.84|
|Wall St. target price||$204.07|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$6.66|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Amedisys price performance over time
|1 week (2022-01-05)||N/A|
|1 month (2021-12-16)||-3.62%|
|3 months (2021-10-12)||N/A|
|6 months (2021-07-16)||-43.20%|
|1 year (2021-01-15)||-50.05%|
|2 years (2020-01-16)||-19.04%|
|3 years (2019-01-16)||16.04%|
|5 years (2017-01-13)||233.77%|
Is Amedisys under- or over-valued?
Valuing Amedisys stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amedisys's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amedisys's P/E ratio
Amedisys's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Amedisys shares trade at around 22x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Amedisys's PEG ratio
Amedisys's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8044. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amedisys's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Amedisys's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $296.6 million.
The EBITDA is a measure of a Amedisys's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.2 billion|
|Operating margin TTM||12.06%|
|Gross profit TTM||$911.2 million|
|Return on assets TTM||9.39%|
|Return on equity TTM||25.99%|
|Market capitalisation||$4.9 billion|
TTM: trailing 12 months
Amedisys share dividends
We're not expecting Amedisys to pay a dividend over the next 12 months.
Have Amedisys's shares ever split?
Amedisys's shares were split on a 4:3 basis on 5 December 2006. So if you had owned 3 shares the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Amedisys shares – just the quantity. However, indirectly, the new 25% lower share price could have impacted the market appetite for Amedisys shares which in turn could have impacted Amedisys's share price.
Amedisys share price volatility
Over the last 12 months, Amedisys's shares have ranged in value from as little as $133.62 up to $325.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amedisys's is 0.6893. This would suggest that Amedisys's shares are less volatile than average (for this exchange).
Amedisys, Inc. , together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia.
Stocks similar to Amedisys
Frequently asked questions
Amedisys in the news
Riverbridge Partners Llc Buys Amedisys Inc, Privia Health Group Inc, Progyny Inc, Sells Gentex ...
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Analysts Expect FXH To Hit $138
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.